The Brenden-Colson Center for Pancreatic Care at OHSU BCCPC recently received notice of U01 funding for the “validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs”. This program establishes a Pancreatic Cancer Detection Consortium (PCDC) Research Unit in collaboration with 6 Universities/Institutes across the country. The objective of the PCDC is to develop and test new molecular and imaging biomarkers for early detection of pancreatic cancer and its precursor lesions to identify high-risk individuals eligible for early intervention.